The report provides a detailed analysis essential for establishing a primaquine production plant. It encompasses all critical aspects necessary for primaquine production, including the cost of primaquine production, primaquine plant cost, primaquine production costs, and the overall primaquine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a primaquine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Primaquine is an 8-aminoquinoline antimalarial medication that targets hepatic hypnozoites of Plasmodium vivax and P. ovale. This prevents relapses after acute infection treatment with blood schizonticides like chloroquine or artemisinin-based therapies. It also effectively kills mature gametocytes of P. falciparum and P. vivax to block malaria transmission from humans to mosquitoes.
It is used in primary prophylaxis for travellers in high P. vivax areas, terminal prophylaxis post-exposure, and single-dose adjuncts in elimination campaigns. It is also used as an alternative therapy for Pneumocystis jirovecii pneumonia when paired with clindamycin. It is administered orally over 14 days for a radical cure, and its common side effects are gastrointestinal disturbances like nausea, vomiting, abdominal cramps, heartburn, and stomach pain.
The market for primaquine is driven by growing cases of P. vivax malaria relapses in endemic regions like the Asia-Pacific and Africa. The WHO-led elimination campaigns and donor initiatives from groups like the Global Fund contribute to its bulk demand. The industrial primaquine procurement is affected by joint purchasing by UN agencies and donors to secure cost-effective generic supplies mainly from Indian manufacturers. Also, the WHO prequalification standards that limit approved suppliers, regulatory requirements which delay rollout and import duty waivers improving affordability in target countries affect its market dynamics. The supply chain hurdles like stockouts in remote areas due to weak infrastructure, along with price fluctuations, elevated production expenses, emerging drug resistance concerns, etc. impacts its sourcing strategies.
Raw Material for Primaquine Production
According to the primaquine production plant project report, the key raw materials used in the production of primaquine include 1,4-dibromopentane, potassium phthalimide, 6-methoxy-8-aminoquinoline, and hydrazine hydrate.
Production Process of Primaquine
The extensive primaquine production cost report consists of the following major industrial production process:
- From 1,4-dibromopentane: The production process of primaquine uses a three-step Gabriel synthesis. First, 1,4-dibromopentane reacts with potassium phthalimide in refluxing acetone for 24-72 hours to form 4-bromo-1-phthalimidopentane. This intermediate then goes through nucleophilic substitution with 6-methoxy-8-aminoquinoline in refluxing ethanol or alcohol to yield the phthalimide-protected primaquine derivative as a dark brown solid. Finally, deprotection occurs via reflux with hydrazine hydrate in alcohol, followed by basification with aqueous KOH, extraction into ether, drying over magnesium sulfate, to give primaquine salt.
Primaquine has a molecular formula of C15H21N3O with a molecular weight of 259.35. It has a quinoline core with a 6-methoxy substituent and an 8-(4-amino-1-methylbutylamino) side chain. It appears as an odourless, bitter-tasting, orange-red crystalline powder that is moderately soluble in water. It is practically insoluble in ethanol, chloroform, or ether, with a melting point around 200 degrees Celsius where it decomposes. Its chemical stability suits sugar-coated tablet formulations for standard storage, while ionizable amine groups and the aliphatic diamine functionality enable oral bioavailability. All these physical and chemical properties make it useful as an 8-aminoquinoline antimalarial medication.
